Skip to main content
Clinical Trials/NCT00968578
NCT00968578
Completed
Phase 4

Effects of Pre-operative Methylprednisolone (125mg iv) After Total Knee Arthroplasty: A Prospective, Randomized, Double-blind, Placebo-controlled Trail

Hvidovre University Hospital1 site in 1 country48 target enrollmentAugust 2009

Overview

Phase
Phase 4
Intervention
Methylprednisolone
Conditions
Postoperative Pain
Sponsor
Hvidovre University Hospital
Enrollment
48
Locations
1
Primary Endpoint
Postoperative pain
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of the study is to compare the effects of pre-operative methylprednisolone (125mg iv) versus placebo on postoperative outcome after knee arthroplasty.

The hypothesis is that pre-operative methylprednisolone (125mg iv) will reduce pain and improve outcome.

Detailed Description

In spite of being one of the last century's most successful surgical procedures in treatment of advanced osteoarthritis total knee arthroplasty is still associated with postoperative pain and delayed rehabilitation. We therefore decided to evaluate the effects of pre-operative methylprednisolone (125mg iv) versus placebo on postoperative outcome in a well defined fast-track setup after knee arthroplasty.

Registry
clinicaltrials.gov
Start Date
August 2009
End Date
December 2009
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Troels Haxholdt Lunn

MD

Hvidovre University Hospital

Eligibility Criteria

Inclusion Criteria

  • Elective total knee arthroplasty
  • Able to speak and understand danish
  • Able to give informed consent

Exclusion Criteria

  • Alcohol or medical abuse
  • Allergies to local anesthetics or methylprednisolone
  • Age \< 18 years
  • Daily use of opioids or glucocorticoids
  • Pregnancy or breastfeeding (fertile women)

Arms & Interventions

Methylprednisolone

Methylprednisolone 125 mg iv pre-operatively

Intervention: Methylprednisolone

Saline

Saline iv pre-operatively in equivalent volume (placebo)

Intervention: Placebo

Outcomes

Primary Outcomes

Postoperative pain

Time Frame: 48 hours + follow up

Secondary Outcomes

  • Fatigue(48 hours + follow up)
  • Postoperative nausea and vomiting (PONV)(48 hours + follow up)
  • Sleeping quality(48 hours + follow up)
  • Inflammatory response(48 hours + follow up)
  • Additional analgetics, antinausea agents and sleeping medicine(48 hours + follow up)
  • Time in hospital(Until discharge)

Study Sites (1)

Loading locations...

Similar Trials